View Clinical Trial (Medical Research Study)
A Multicenter Study to Evaluate the Efficacy of DR-105 for Menstrually-Related Migraine Headaches - NCT00781456-92618(Clinical Trial 249724)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Irvine |
|
State:
|
|
CA |
| Zip Code: |
|
92618 |
| Conditions: |
|
Migraine |
| Purpose: |
|
This study is being conducted to evaluate the efficacy of DR-105 compared to placebo for
decreasing the frequency and severity of menstrually-related migraine headaches.
|
| Study summary: |
|
This is a multicenter, randomized, study to evaluate and compare the frequency and severity
of menstrually-related migraine headaches before and during the 7-day ethinyl estradiol
monotherapy interval in women treated with DR-105 compared to placebo during the 91-day
treatment period. |
| Criteria: |
|
Inclusion Criteria:
- Premenopausal, non-pregnant, non-lactating
- History of migraine headaches without aura for at least 6 months
- History of migraine headaches associated with menstruation
- Others as directed by FDA-approved protocol
Exclusion Criteria:
- History of migraine headaches with aura or focal neurological symptoms
- Any contraindication to the use of oral contraceptives
- Others as dictated by FDA-approved protocol |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|